Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerio Ricci

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
The International Journal of Neuropsychopharmacology|January 18, 2016
Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive SymptomsGiovanni Martinotti, Mauro Pettorruso, Domenico De Berardis, et al.
Journal of Clinical Medicine|April 27, 2024
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World InvestigationClara Cavallotto, Stefania Chiappini, Alessio Mosca, et al.
Pharmaceuticals (Basel, Switzerland)|April 27, 2024
Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World StudyStefania Chiappini, Clara Cavallotto, Alessio Mosca, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Preliminary Evidence on the Efficacy and Tolerability of Quetiapine in Dual Disorders: A Prospective, Multicentric, Real-World StudyAlessio Mosca, Clara Cavallotto, Stefania Chiappini, et al.
Journal of Geriatric Psychiatry and Neurology|May 23, 2026
The Late-Life Depression a Comprehensive Review of Clinical, Pathophysiological, and Therapeutic ConsiderationsThomas Fraccalini, Beatrice Tarozzo, Thomas Roberts, et al.
Journal of Clinical Psychopharmacology|December 30, 2022
Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With SchizophreniaAlessandro Cuomo, Eugenio Aguglia, Stefano Biagini, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 29, 2026
The Clinical Impact of Sarcopenia and Delirium in Hospitalized Elderly Patients: An Analysis Using Muscle UltrasoundThomas Fraccalini, Laura Santos Ribeiro, Andrea Trogolo, et al.
Eclinicalmedicine|September 21, 2023
Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individualsMathilde Argote, Guillaume Sescousse, Jérôme Brunelin, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
The International Journal of Neuropsychopharmacology|January 18, 2016
Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive SymptomsGiovanni Martinotti, Mauro Pettorruso, Domenico De Berardis, et al.
Journal of Clinical Medicine|April 27, 2024
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World InvestigationClara Cavallotto, Stefania Chiappini, Alessio Mosca, et al.
Pharmaceuticals (Basel, Switzerland)|April 27, 2024
Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World StudyStefania Chiappini, Clara Cavallotto, Alessio Mosca, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Preliminary Evidence on the Efficacy and Tolerability of Quetiapine in Dual Disorders: A Prospective, Multicentric, Real-World StudyAlessio Mosca, Clara Cavallotto, Stefania Chiappini, et al.
Journal of Geriatric Psychiatry and Neurology|May 23, 2026
The Late-Life Depression a Comprehensive Review of Clinical, Pathophysiological, and Therapeutic ConsiderationsThomas Fraccalini, Beatrice Tarozzo, Thomas Roberts, et al.
Journal of Clinical Psychopharmacology|December 30, 2022
Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With SchizophreniaAlessandro Cuomo, Eugenio Aguglia, Stefano Biagini, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 29, 2026
The Clinical Impact of Sarcopenia and Delirium in Hospitalized Elderly Patients: An Analysis Using Muscle UltrasoundThomas Fraccalini, Laura Santos Ribeiro, Andrea Trogolo, et al.
Eclinicalmedicine|September 21, 2023
Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individualsMathilde Argote, Guillaume Sescousse, Jérôme Brunelin, et al.
Pageof 8